Treatment of Renal Kidney Stones with the Monarch Platform
Jaime Landman
- OPEN TO ACCRUAL
trials found matching your search:
Displaying 20 of 260 Results
PhIII, RandomPlacebo-controlled MultiTrial Selinex Mainten Systemic Pa w/P53WildtypeEndometrial Ca
Krishnansu Tewari
- OPEN TO ACCRUAL
A Phase I Study of KSQ-4279 Alone and in Combination in Patients with Advanced Solid Tumors
Krishnansu Tewari
- SUSPENDED
PhII Immune Checkpoint Combos w/Axitinib in Pts w/Prev Untreated Local AdvUnresec or Metastatic RCC
Nataliya Mar
- OPEN TO ACCRUAL
Randomized PhIII Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Meta Colorectal Ca
Fa Chyi Lee
- OPEN TO ACCRUAL
Pragmatic RandomPhIII Trial Eval Total AblativeThe Pa w/Limited MetaColoRecCa Eval Rad Ablation&Surg
Oliver Eng
- OPEN TO ACCRUAL
Bone Marrow Mesenchymal Stem Cell for COVID-19 related ARDS
Alpesh Amin
- OPEN TO ACCRUAL
Ph Ib/II ACR-368 as Monother& Comb w/Gemcitabine in Plat-Res Ovarian Ca Endometrial Adenoca &Urothel
Nataliya Mar
- OPEN TO ACCRUAL
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (ADAPT)
Stefan Octavian Ciurea
- OPEN TO ACCRUAL
PROJECT-BARI
Kishore Gadde
- OPEN TO ACCRUAL
Intermediate-Sized Expanded Access Study
Namita Goyal
- OPEN TO ACCRUAL
Ironwood C3300-201
Dena Moskowitz
- OPEN TO ACCRUAL
PhIII Inavolisib+FulvestrantVSAlpelisib+Fulvestrant Pa w/HormoneRecep+ HER2- PIK3CA BreastCa
Ritesh Parajuli
- OPEN TO ACCRUAL
PhII Consolidation Therapy for Relapsed/Refractory LargeB-CellLympoma or GradeIIIBFollicularLymphoma
Elizabeth A Brem
- OPEN TO ACCRUAL
PhI/II Study of HM43239 in Patients with Relapsed or Refractory AML
Deepa Jeyakumar
- OPEN TO ACCRUAL
PhI/II FirstInHuman Study DF9001 Comb w/Nivolumab Pa w/Solid Tumors Selected Indications
Jennifer Brooke Valerin
- OPEN TO ACCRUAL
A Phase I/II, Multicenter, Open-Label, Single-Dose, Dose-Ranging Study
Madeleine Pahl
- OPEN TO ACCRUAL
Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients with Symptomatic Gen
Ali A Habib
- OPEN TO ACCRUAL
Pre-Gene Therapy Study in Parkinsons Disease and Multiple System Atrophy
Nicolas Phielipp
- OPEN TO ACCRUAL
SAFETY STUDY OF AAV2-GDNF IN MSA
Nicolas Phielipp
- OPEN TO ACCRUAL